VRK2 Rekombinanter Antikörper
VRK2 Rekombinant Antikörper für WB, Cytometric bead array, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, Cytometric bead array, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
242180B2
Kat-Nr. : 84663-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
84663-1-PBS bindet in WB, Cytometric bead array, Indirect ELISA VRK2 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | VRK2 fusion protein Ag4019 |
| Vollständiger Name | vaccinia related kinase 2 |
| Berechnetes Molekulargewicht | 508 aa, 58 kDa |
| Beobachtetes Molekulargewicht | 58 kDa |
| GenBank-Zugangsnummer | BC027854 |
| Gene symbol | VRK2 |
| Gene ID (NCBI) | 7444 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Vaccinia-related kinase 2 (VRK2) is a serine/threonine kinase that plays a significant role in various cellular processes, including cell survival, proliferation, and DNA damage response. The VRK2 gene is known to produce two main splice variants: VRK2A and VRK2B, with VRK2A being the predominant form in humans. VRK2 is involved in several key biological functions. It is known to enhance cell survival by acting as an anti-apoptotic factor, which is particularly crucial in cancer biology. The overexpression of VRK2 has been linked to increased drug sensitivity in cancer cells, suggesting that this kinase may play a role in therapeutic responses. Additionally, high levels of VRK2 protein have been associated with improved survival rates in specific subgroups of astrocytomas, a type of brain tumor. (PMID: 29872222; 37943248; 24079673)





